Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection

Claudio Galvao de Castro Jr.Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil; Correspondence[email protected] [email protected]

http://orcid.org/0000-0002-4610-8282

Lauro Jose GregianinHospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil; ;Pediatric Department, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil;

http://orcid.org/0000-0003-0788-7858

Jan A. BurgerDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

http://orcid.org/0000-0002-6177-7572

"Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection." Leukemia & Lymphoma, 61(10), pp. 2536–2537

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection

Information for

Open access

Opportunities

Help and information

Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature